182 related articles for article (PubMed ID: 18018406)
1. [Life style changes in heart patients. Is your record as bad, too?].
Einecke D
MMW Fortschr Med; 2007 Sep; 149(38):12-3. PubMed ID: 18018406
[No Abstract] [Full Text] [Related]
2. [Methods of influencing life style and risk factors].
Mancini M; Contaldo F; Cortese C; Farinaro E; Ferrara LA; Giumetti D; Panico S; Postiglione A; Riccardi G; Rivellese A
G Ital Cardiol; 1989 Sep; 19(9):787-99; discussion 811-9. PubMed ID: 2612824
[No Abstract] [Full Text] [Related]
3. [Epidemiology of coronary disease: a review of the literature].
Paradis GB; Battista RN; Miranda PS; Spitzer WO; Tremblay J
Union Med Can; 1985 Mar; 114(3):190-8. PubMed ID: 3890313
[No Abstract] [Full Text] [Related]
4. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
[No Abstract] [Full Text] [Related]
5. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
[No Abstract] [Full Text] [Related]
6. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
[TBL] [Abstract][Full Text] [Related]
7. Coronary risk factor statement for the American public. A statement of the nutrition committee.
Grundy SM; Arky R; Bray GA; Brown WV; Ernst ND; Kwiterovich PO; Mattson F; Weidman WH; Schonfeld G; Strong JP
Circulation; 1985 Nov; 72(5):1135A-1139A. PubMed ID: 4042301
[No Abstract] [Full Text] [Related]
8. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of coronary risk factors in a rural community of Andhra Pradesh.
Kokiwar PR; Rao JG; Shafee MD
Indian J Public Health; 2009; 53(1):52-4. PubMed ID: 19806833
[TBL] [Abstract][Full Text] [Related]
10. [New goals in secondary prevention. "It does not make sense to stop at 100 mg/dl LDL"].
Klör HU
MMW Fortschr Med; 2005 Mar; 147(12):5. PubMed ID: 15832779
[No Abstract] [Full Text] [Related]
11. Association of diabetes mellitus and dyslipidaemias in the Tehran population.
Ghoddusi K; Ameli J; Kachuee H; Pourfarziani V; Saadat A; Karami Q
East Mediterr Health J; 2008; 14(3):647-53. PubMed ID: 18720629
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of coronary and contributory risk factors in rural and urban type 2 diabetics.
Jha N
Kathmandu Univ Med J (KUMJ); 2004; 2(1):28-34. PubMed ID: 19780285
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of ischemic heart disease and its primary risk factors by ergometric studies at the Mecsek Ore Mining Company].
Fenyvesi E; Pórszász J; Simor T
Orv Hetil; 1988 Jan; 129(3):135-40. PubMed ID: 3353109
[No Abstract] [Full Text] [Related]
15. [Prevalence and risk factors of peripheral arterial occlusive diseases and coronary heart disease].
Müller-Bühl U; Diehm C; Sieben U; Berger B; Schuler G; Zimmermann R; Scheuermann W; Heuck CC; Mörl H; Kübler W
Vasa Suppl; 1987; 21():1-46. PubMed ID: 3324366
[No Abstract] [Full Text] [Related]
16. Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4.
Gupta R; Kaul V; Bhagat N; Agrawal M; Gupta VP; Misra A; Vikram NK
Indian Heart J; 2007; 59(4):346-53. PubMed ID: 19126941
[TBL] [Abstract][Full Text] [Related]
17. [Conservative treatment of coronary heart disease--current options].
Desch S; Schuler G; Niebauer J
MMW Fortschr Med; 2005 Feb; 147(8):45-7. PubMed ID: 18437860
[TBL] [Abstract][Full Text] [Related]
18. Is atherosclerosis reversible? Are we doing enough to reverse it?
Glancy DL; Lopez-S A; Vijayagopal P
J La State Med Soc; 2002; 154(3):126-9. PubMed ID: 12141294
[No Abstract] [Full Text] [Related]
19. Prevention of coronary heart disease in post-menopausal women.
Cullen P; von Eckardstein A; Barrett-Connor E; Lewis B; Mancini M; Riesen W; Schober O; Fruchart JC; Schwandt P; Assmann G;
Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):267-74. PubMed ID: 11213536
[No Abstract] [Full Text] [Related]
20. Coronary heart disease and associated risk factors in Qazvin: a population-based study.
Fakhrzadeh H; Bandarian F; Adibi H; Samavat T; Malekafzali H; Hodjatzadeh E; Larijani B
East Mediterr Health J; 2008; 14(1):33-41. PubMed ID: 18557450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
